The higher the proportion of the ATII-CCL20 cell subtype, the more pronounced the lipid metabolism abnormalities, and the more severe the fibrosis and poorer prognosis in IPF patients. This evidence concerns the gene CCL20 and idiopathic pulmonary fibrosis.